Trimetazidine with an adjuvant therapy to normalize the circulating visfatin concentration: Future perspective and mechanistic strategies
Visfatin is an adipocytokine that exists in two forms, intracellular and extracellular. Circulating visfatin, which lacks the nicotinamide phosphoribosyltransferase (NAMPT) enzyme activity, functions as adipocytokine. Increased concentration of circulating visfatin is associated with several disease...
Main Authors: | G. Uma Maheswari, B. Yamini, Ajay Guru, Manikandan Velayutham, V.E. Dhandapani, Kanchana M. Karuppiah, Nicholas Daniel Amalorpavanaden |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-12-01
|
Series: | Journal of King Saud University: Science |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1018364723004123 |
Similar Items
-
Metabolic modulators in cardioprotection: A focus on trimetazidine
by: Du Qingyou
Published: (2024-01-01) -
Tissue Expression of Visfatin in Psoriatic Patients
by: Abd El-Aziz El-Rifaie, et al.
Published: (2022-10-01) -
AN EXPERIENCE OF TRIMETAZIDINE USAGE IN COMORBIDITY
by: I. V. Kochetkova, et al.
Published: (2018-04-01) -
The cardioprotective role of trimetazidine on cisplatin-induced cardiotoxicity
by: Murathan Küçük, et al.
Published: (2020-01-01) -
Breastfeeding effects on visfatin levels in postpartum women
by: Ching-Ju Shen, et al.
Published: (2015-06-01)